Kathleen Corey Flanders
#138,250
Most Influential Person Now
Kathleen Corey Flanders's AcademicInfluence.com Rankings
Kathleen Corey Flandersbiology Degrees
Biology
#9613
World Rank
#12837
Historical Rank
Immunology
#573
World Rank
#592
Historical Rank
Biochemistry
#1482
World Rank
#1609
Historical Rank
Download Badge
Biology
Kathleen Corey Flanders's Degrees
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Kathleen Corey Flanders Influential?
(Suggest an Edit or Addition)Kathleen Corey Flanders's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. (1993) (2028)
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells (1987) (1049)
- Transforming Growth Factor‐β (1990) (1002)
- Role of transforming growth factor-beta in the development of the mouse embryo (1987) (769)
- Smad3 as a mediator of the fibrotic response (2004) (587)
- Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. (1988) (531)
- Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. (1991) (524)
- Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro (1987) (519)
- Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. (1988) (502)
- Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice (1989) (455)
- Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in culture (1989) (419)
- In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis (1989) (404)
- Localization and actions of transforming growth factor-beta s in the embryonic nervous system. (1991) (387)
- Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. (1992) (376)
- Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes (1989) (374)
- Erythropoietin receptor signalling is required for normal brain development. (2002) (351)
- Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. (2006) (346)
- TRANSFORMING GROWTH FACTOR-βS IN NEURODEGENERATIVE DISEASE (1998) (341)
- TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. (1996) (321)
- Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. (1989) (319)
- Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system (1991) (306)
- A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. (1999) (302)
- Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease (1996) (290)
- Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. (2004) (284)
- Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. (2002) (279)
- Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. (1988) (276)
- Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes (2006) (273)
- Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. (1991) (254)
- Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. (1991) (243)
- Cell type-specific expression of transforming growth factor-beta 1 in the mouse uterus during the periimplantation period. (1990) (242)
- TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases. (1993) (240)
- Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis. (1990) (238)
- Smad3: A Key Player in Pathogenetic Mechanisms Dependent on TGF‐β (2003) (236)
- Transforming growth factor beta-1 in acute myocardial infarction in rats. (1988) (220)
- Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. (1993) (220)
- Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). (1992) (217)
- TGF-β and Smad3 Signaling Link Inflammation to Chronic Fibrogenesis1 (2005) (216)
- Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. (1986) (205)
- Amelioration of Radiation-induced Fibrosis (2004) (183)
- Transforming growth factor-beta: multifunctional regulator of differentiation and development. (1990) (183)
- Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study. (1993) (179)
- Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis. (1995) (175)
- Differential effects of transforming growth factor β on human prostate cancer cells in vitro (1989) (171)
- Loss of Smad3 in acute T-cell lymphoblastic leukemia. (2004) (171)
- Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. (2003) (168)
- Murine pregnancy decidua produces a unique immunosuppressive molecule related to transforming growth factor beta-2. (1990) (165)
- Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. (1996) (163)
- Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization. (1989) (159)
- Transforming growth factor-beta. Major role in regulation of extracellular matrix. (1990) (158)
- Expression of transforming growth factor-beta isoforms (beta 2 and beta 3) in the mouse uterus: analysis of the periimplantation period and effects of ovarian steroids. (1992) (155)
- Accumulation, localization, and compartmentation of transforming growth factor beta during endochondral bone development (1988) (154)
- Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. (1997) (153)
- Altered expression of transforming growth factor-beta in Alzheimer's disease (1995) (151)
- Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice (2004) (146)
- Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. (1994) (140)
- TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. (2005) (139)
- Transforming growth factor-betas in neurodegenerative disease. (1998) (137)
- Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sites. (1994) (135)
- Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia. (1996) (133)
- Complex regulation of TGF beta expression by retinoic acid in the vitamin A-deficient rat. (1991) (132)
- Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta 1. (1992) (131)
- Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. (2005) (124)
- Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. (1994) (123)
- Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. (1988) (121)
- TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. (1993) (121)
- Interactions between retinoids and TGF beta s in mouse morphogenesis. (1992) (117)
- Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages. (1992) (117)
- Localization of transforming growth factor-beta isotypes in lesions of the human breast. (1992) (115)
- Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? (2001) (111)
- Antibodies to peptide determinants in transforming growth factor beta and their applications. (1988) (110)
- Transforming growth factor-β1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer (1995) (107)
- Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice. (2005) (104)
- A Subset of Patients With Recurrent Spontaneous Abortion Is Deficient in Transforming Growth Factor β‐2‐Producing “Suppressor Cells” in Uterine Tissue Near the Placental Attachment Site (1995) (98)
- Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine‐induced hepatic fibrosis in mice (2009) (95)
- Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial–mesenchymal transition of lens epithelium in mice (2004) (95)
- A Flexible Reporter System for Direct Observation and Isolation of Cancer Stem Cells (2014) (92)
- Immunohistochemical expression of smads 1–6 in the 15‐day gestation mouse embryo: signaling by BMPs and TGF‐βs † (2001) (90)
- Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer. (1993) (89)
- Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. (2009) (88)
- Transient Tumor-Fibroblast Interactions Increase Tumor Cell Malignancy by a TGF-β Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer (2010) (88)
- Localization and binding of transforming growth factor-beta isoforms in mouse preimplantation embryos and in delayed and activated blastocysts. (1992) (87)
- Expression of transforming growth factor-beta s 1-4 in chicken embryo chondrocytes and myocytes. (1991) (86)
- Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis. (1994) (85)
- CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel transforming growth factor-beta 2-related immunosuppressive factors. (1994) (84)
- Expression of Tumor Necrosis Factor-α and Transforming Growth Factor-β1 in Acute Liver Injury (1989) (83)
- Release of a transforming growth factor (TGF)-beta 2-related suppressor factor from postimplantation murine decidual tissue can be correlated with the detection of a subpopulation of cells containing RNA for TGF-beta 2. (1992) (80)
- TRPV1 involvement in inflammatory tissue fibrosis in mice. (2011) (78)
- Conditional overexpression of TGF-β1 disrupts mouse salivary gland development and function (2010) (78)
- Loss of Tumor Necrosis Factor α Potentiates Transforming Growth Factor β-mediated Pathogenic Tissue Response during Wound Healing (2006) (77)
- Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral Leishmaniasis (2005) (76)
- Transforming Growth Factor-βs and Mammary Gland Involution; Functional Roles and Implications for Cancer Progression (2009) (75)
- Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. (1989) (75)
- Smad3 deficiency alters key structural elements of the extracellular matrix and mechanotransduction of wound closure. (2006) (75)
- Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. (2006) (75)
- Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue. (1995) (74)
- Localization of transforming growth factor-beta 1 in mitochondria of murine heart and liver. (1991) (74)
- Discordant transforming growth factor beta 1 RNA and protein localization during chemical carcinogenesis of the skin. (1992) (73)
- Transforming growth factors beta 1, beta 2, and beta 3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: a comparison to other estrogen-regulated genes. (1994) (73)
- Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice. (2007) (70)
- Expression, localization, and function of transforming growth factor-beta s in embryonic chick spinal cord, hindbrain, and dorsal root ganglia. (1996) (70)
- Epithelial-mesenchymal transition as a therapeutic target for prevention of ocular tissue fibrosis. (2008) (68)
- Transforming growth factor β1 as a biomarker for prostate cancer (1992) (68)
- Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells. (2003) (67)
- Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics (2010) (67)
- Transforming growth factors-β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide (1996) (66)
- SNIP1 Inhibits NF-κB Signaling by Competing for Its Binding to the C/H1 Domain of CBP/p300 Transcriptional Co-activators* (2001) (65)
- Medical Applications of Transforming Growth Factor-β (2003) (65)
- Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells (2005) (63)
- Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. (2001) (63)
- Transforming Growth Factor‐β1 in Normal Heart and in Myocardial Infarction (1990) (62)
- Regulation of type II alveolar epithelial cell proliferation by TGF-beta during bleomycin-induced lung injury in rats. (1994) (62)
- Transforming growth factor beta 1 is an epithelial-derived signal peptide that influences otic capsule formation. (1992) (61)
- Antibodies to transforming growth factor-β2 peptides: Specific detection of TGF-β2 in immunoassays (1990) (61)
- Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice (2005) (61)
- TRPA1 is required for TGF-β signaling and its loss blocks inflammatory fibrosis in mouse corneal stroma (2014) (60)
- Altered expression of transforming growth factor‐β1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix (1996) (58)
- Transgenic models for the study of prostate cancer (1993) (57)
- Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid–induced colorectal fibrosis (2009) (57)
- Presence and regulation of transforming growth factor beta mRNA and protein in the normal and lesioned rat sciatic nerve (1994) (57)
- Deficient transforming growth factor-beta1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors. (1997) (57)
- Autoinduction of mRNA and protein expression for transforming growth factor-beta S in cultured cardiac cells. (1995) (56)
- Transforming Growth Factor 81 Positively Regulates Its Own Expression in Normal and Transformed Cells * (2001) (54)
- Effects of TGF-βs and bFGF on Astroglial Cell Growth and Gene Expression in Vitro (1993) (54)
- Effect of Smad7 gene overexpression on transforming growth factor beta-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse model. (2007) (52)
- Effects of Transforming Growth Factor-β (Isoforms 1–3) on Amyloid-β Deposition, Inflammation, and Cell Targeting in Organotypic Hippocampal Slice Cultures (1998) (50)
- GATA3 Inhibits Lysyl Oxidase Mediated Metastases of Human Basal Triple-Negative Breast Cancer Cells (2011) (50)
- Role of Smad3 in the hormonal modulation of in vivo wound healing responses (2003) (49)
- Human fallopian tube expresses transforming growth factor (TGF beta) isoforms, TGF beta type I-III receptor messenger ribonucleic acid and protein, and contains [125I]TGF beta-binding sites. (1994) (48)
- Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF‐β (1994) (47)
- Localization of seminal plasma transforming growth factor-beta1 on human spermatozoa: an immunocytochemical study. (1996) (47)
- Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. (2015) (47)
- Transforming growth factor-beta: neuronal and glial expression in CNS degenerative diseases. (1995) (46)
- Distribution of transforming growth factor‐β isoforms in the mammalian retina (1995) (46)
- Smad‐3 as a mediator of the fibrotic response (2004) (45)
- Transforming growth factor-β protects human hNT cells from degeneration induced by β-amyloid peptide: involvement of the TGF-β type II receptor (1997) (44)
- Transforming growth factor-β inhibits apoptosis induced by β-amyloid peptide fragment 25–35 in cultured neuronal cells (1998) (44)
- Characterization of the mouse Smad1 gene and its expression pattern in adult mouse tissues. (2000) (42)
- Increased expression of growth factor mRNAs accompanies viral transformation of rodent cells. (1988) (42)
- A new model of anterior subcapsular cataract: involvement of TGFbeta/Smad signaling. (2006) (40)
- Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing. (2006) (39)
- Inducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man. (1998) (38)
- TGF‐β Rescues Target‐deprived Preganglionic Sympathetic Neurons in the Spinal Cord (1996) (38)
- Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. (1995) (36)
- Induction of transforming growth factor beta in hormonally treated human prostate cancer. (1994) (36)
- Characterization of murine pregnancy decidua transforming growth factor beta. I. Transforming growth factor beta 2-like molecules of unusual molecular size released in bioactive form. (1995) (33)
- Hyperthermia induces expression of transforming growth factor-beta s in rat cardiac cells in vitro and in vivo. (1993) (33)
- Impaired cornea wound healing in a tenascin C-deficient mouse model (2013) (32)
- TGF-β receptors-I and -II immunoexpression in Alzheimer’s disease: a comparison with aging and progressive supranuclear palsy (1998) (32)
- Transforming Growth Factor-β3 (TGF-β3) Knock-in Ameliorates Inflammation Due to TGF-β1 Deficiency While Promoting Glucose Tolerance* (2013) (31)
- Transforming Growth Factor‐β: Multifunctional Regulator of Cell Growth and Phenotype (1988) (31)
- Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium (2007) (31)
- Mammary epithelial cell phagocytosis downstream of TGF-β3 is characterized by adherens junction reorganization (2015) (30)
- Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures. (1998) (29)
- Definition of smad3 phosphorylation events that affect malignant and metastatic behaviors in breast cancer cells. (2014) (28)
- Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1. (2017) (27)
- Suppression of injury-induced epithelial-mesenchymal transition in a mouse lens epithelium lacking tenascin-C (2010) (26)
- Expression of transforming growth factor-β isoforms in the rat male accessory sex organs and epididymis (1998) (26)
- Transforming growth factor β1 induction is associated with transforming growth factors β2 and β3 down-modulation in 12-O-tetradecanoylphorbol-13-acetate-induced skin hyperplasia (1993) (25)
- Medical applications of transforming growth factor-beta. (2003) (25)
- Transforming growth factor‐β3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma (1997) (24)
- TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury[S] (2012) (23)
- Differential effects of transforming growth factor-βs and glial cell line-derived neurotrophic factor on gene expression of presenilin-1 in human post-mitotic neurons and astrocytes (1999) (22)
- Transforming growth factor-beta inhibits apoptosis induced by beta-amyloid peptide fragment 25-35 in cultured neuronal cells. (1998) (22)
- Distribution of transforming growth factor-beta isoforms in the mammalian retina. (1995) (21)
- Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide. (1996) (20)
- An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer (2014) (19)
- Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury. (1989) (19)
- Absence of Smad3 induces neutrophil migration after cutaneous irradiation: possible contribution to subsequent radioprotection. (2008) (19)
- Analogous tamoxifen and estrogen effects on transforming growth factor-betas 1 and 2 in the rat uterus. (1995) (19)
- Halofuginone mediated protection against radiation-induced leg contracture. (2009) (19)
- Glucagon carboxyl-terminal derivatives: preparation, purification, and characterization. (1982) (18)
- Biological Responses to TGF-β in the Mammary Epithelium Show a Complex Dependency on Smad3 Gene Dosage with Important Implications for Tumor Progression (2012) (18)
- Semisynthetic derivatives of glucagon: (des-His1)N epsilon-acetimidoglucagon and N alpha-Biotinyl-N epsilon-acetimidoglucagon. (1982) (18)
- Inhibition of development of laser-induced choroidal neovascularization with suppression of infiltration of macrophages in Smad3-null mice (2016) (18)
- Noncooperative receptor interactions of glucagon and eleven analogues: inhibition of adenylate cyclase. (1983) (18)
- Kainate treatment alters TGF-beta3 gene expression in the rat hippocampus. (2002) (18)
- Transforming growth factor-beta s in mammary tumorigenesis: promoters or antipromoters? (1995) (17)
- Colocalization of TGF-beta 1 and extracellular matrix proteins during rat tooth development. (1992) (17)
- Transforming growth factor-betas block cytokine induction of catalase and xanthine oxidase mRNA levels in cultured rat cardiac cells. (1997) (17)
- ENDOCRINE EXPRESSION OF THE ACTIVE FORM OF TGF-β1 IN THE TGF-β1 NULL MICE FAILS TO AMELIORATE LETHAL PHENOTYPE (2002) (17)
- Absence of Smad3 confers radioprotection through modulation of ERK-MAPK in primary dermal fibroblasts. (2007) (17)
- Characterization of mutated transforming growth factor-beta s which possess unique biological properties. (1994) (17)
- Transforming growth factor beta 1 as a biomarker for prostate cancer. (1992) (16)
- Distribution of acidic fibroblast growth factor, basic fibroblast growth factor, and transforming growth factor β1 in rat growth plate (1990) (15)
- Brightfield Proximity Ligation Assay Reveals Both Canonical and Mixed Transforming Growth Factor-β/Bone Morphogenetic Protein Smad Signaling Complexes in Tissue Sections (2014) (15)
- Molecular control of neural plasticity by the multifunctional growth factor families of the FGFs and TGF-beta s. (1992) (15)
- Impaired healing of cornea incision injury in a TRPV1-deficient mouse (2018) (15)
- Immunohistochemical localization of transforming growth factor-beta 1 in Kaposi's sarcoma. (1995) (14)
- Histochemical localization of transforming growth factor-beta 1 in developing rat molars using antibodies to different epitopes. (1990) (14)
- The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models In Vivo Reflects a Complex Balance between Tumor-Suppressive and Proprogression Activities of TGFβ (2019) (14)
- Transforming Growth Factor-/ l: Histochemical Localization with Antibodies to Different Epitopes (2002) (14)
- [25-oxindolylalanine]glucagon and [27-methionine sulfoxide]glucagon: preparation, purification, and characterization. (1982) (13)
- Temporal changes in expression of TGF-beta isoforms in mouse lung exposed to oxygen. (1997) (13)
- Transforming growth factor‐β1 expression in early biopsy specimen predicts long‐term graft function following pediatric renal transplantation (2001) (12)
- Role of a Unique Species of Transforming Growth Factor Beta in Preventing Rejection of the Conceptus During Pregnancy (1993) (12)
- TGF-beta receptors-I and -II immunoexpression in Alzheimer's disease: a comparison with aging and progressive supranuclear palsy. (1998) (12)
- Suppression of In Vivo Neovascularization by the Loss of TRPV1 in Mouse Cornea (2015) (11)
- Transforming growth factor-beta protects human hNT cells from degeneration induced by beta-amyloid peptide: involvement of the TGF-beta type II receptor. (1997) (11)
- Effect of overexpression of pparγ on the healing process of comeal alkali burn in mice (2007) (11)
- Osteoblasts Synthesize and Respond to Transforming Growth Factor-Type [3 In Vitro (2003) (11)
- Discordant Transforming Growth Factor / 3 RNA and Protein Localization during Chemical Carcinogenesis of the Skin 1 (2005) (10)
- Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium (2016) (10)
- Endocrine expression of the active form of TGF-beta1 in the TGF-beta1 null mice fails to ameliorate lethal phenotype. (2002) (8)
- Biosynthesis of an asparagine-linked oligosaccharide-containing calcitonin by a rat medullary thyroid carcinoma cell line. (1986) (8)
- Semisynthetic derivatives of glucagon. The contribution of histidine-1 to hormone conformation and activity. (1984) (8)
- Transforming growth factor-beta 1 in normal heart and in myocardial infarction. (1990) (7)
- The Trophic Cocktail Made by Chromaffin Cells (1992) (7)
- The effects of retinoid status on TGF β expression during mouse embryogenesis (1995) (7)
- Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system (2000) (6)
- Transforming Growth Factor β: A Multifunctional Regulatory Peptide with Actions in the Reproductive System (1991) (5)
- Immunohistochemical Localization of TGFβ2 and β3 in the Nervous System (1990) (5)
- Semisynthetic d-His1,Nϵ-acetimidoglucagon: Structure-function relationships (1987) (5)
- The effects of retinoid status on TGF beta expression during mouse embryogenesis. (1995) (4)
- In Vitro and In Vivo Association of Transforming Growth Factor- l with Hepatic Fibrosis (2002) (4)
- Antibodies to transforming growth factor-beta 2 peptides: specific detection of TGF-beta 2 in immunoassays. (1990) (4)
- Transforming growth factor-beta1 expression in early biopsy specimen predicts long-term graft function following pediatric renal transplantation. (2001) (3)
- and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells (2013) (2)
- Advances in Brief A Novel Synthetic Oleanane Triterpenoid , 2-Cyano-3 , 12-dioxoolean-1 , 9-dien-28-oic Acid , with Potent Differentiating , Antiproliferative , and Anti-Inflammatory Activity 1 (1999) (2)
- Transforming growth factor beta 1 induction is associated with transforming growth factors beta 2 and beta 3 down-modulation in 12-O-tetradecanoylphorbol-13-acetate-induced skin hyperplasia. (1993) (2)
- Human endothelial cells synthesize fibroblast growth factor and transforming growth factor beta (1987) (2)
- Transforming growth factor-beta 1 specifically localizes in elastin during synovial inflammation: an immunoelectron microscopic study. (1990) (2)
- Novel Transforming Growth Factor Betas (TGFβ2) in Pregnancy and Cancer (1994) (2)
- Distribution of transforming growth factor beta in a two-week-old human embryo. (1992) (2)
- Impaired healing of cornea incision injury in a TRPV1-deficient mouse (2018) (2)
- Transforming Growth Factor‐β1 Is Expressed and Synthesized during Fracture Healing (1990) (2)
- Abstract 2221: Transforming Growth Factor-beta (TGF-β) directly regulates breast cancer stem cell dynamics in vitro and in vivo (2015) (1)
- Transient adenoviral gene transfer of Smad7 prevents formation of ulceration and scarring of the cornea following an alkali exposure in mice (2004) (1)
- Effects of Transforming Growth Factor-b ( Isoforms 1 – 3 ) on Amyloid-b Deposition , Inflammation , and Cell Targeting in Organotypic Hippocampal Slice Cultures (1998) (1)
- S-22-2 Growth factors as products and regulators of astrocytes: CNTF, FGF, TGF-β1–3, and GDNF (1995) (1)
- Transforming Growth Factor‐TGFβ and Fibronectin, Collagens I and III, and Glycosaminoglycans in the Developing Mouse Embryo a (1990) (1)
- TGF-- SMAD 3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury (1)
- Abstract B13: Targeting the TGF-β pathway in breast cancer: Insights from preclinical studies (2016) (0)
- Progressive Tumor Formation in Mice with Conditional Deletion of TGF- B Signaling in Head and Neck Epithelia Is Associated with Activation of the PI3K/Akt Pathway Molecular Biology, Pathobiology, and (2009) (0)
- Role in HBV Pathogenesis (1996) (0)
- TRANSFORMING GROWTH FACTOR-β EXPRESSION IN NEURODEGENERATIVE DISEASES: 135 (1995) (0)
- ESTROGEN AND ALZHEIMERʼS DISEASE: COULD THE TGF-B SYSTEM BE INVOLVED? (1998) (0)
- Retinoic acidinduces transforming growth factor-fl2 in cultured keratinocytes andmouse epidermis (1989) (0)
- in Pregnancy and Cancer (1994) (0)
- Transforming growth factor-beta in the developing embyro (1989) (0)
- Molecular and Cellular Pathobiology De fi nition of Smad 3 Phosphorylation Events That Affect Malignant and Metastatic Behaviors in Breast Cancer Cells (2014) (0)
- Semisynthetic D-His1,N epsilon-acetimidoglucagon: structure-function relationships. (1987) (0)
- Resource A Flexible Reporter System for Direct Observation and Isolation of Cancer Stem Cells (2014) (0)
- Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine -induced hepatic fibrosis in mice (2010) (0)
- Targeted disruption of Smad 3 confers resistance to the developmentof dimethylnitrosamine-induced hepatic ¢ brosis inmice (2009) (0)
- An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer (2014) (0)
- Transforming growth factor-beta — mediator of carcinogenesis, inflammation and embryonic development (1988) (0)
- Expression and Binding of Transforming Growth Factor ßs in the Mouse Embryo and Uterus During the Periimplantation Period (1993) (0)
- Localization oftransforming growth factor-,B1 inmitochondria ofmurine heart andliver (1991) (0)
- TGF Beta-Smad3 Signaling Is Required for Epithelial-Mesenchymal Transition of Lens Epithelium (2003) (0)
- Abstract A81: Relationships between expression of TGF-β factors and breast tumor characteristics in a population-based study from Poland (2009) (0)
- Immunolocalization of transforming growth factor 1 and 2 in human ovarian tumors (1992) (0)
- Abstract 4094: Neutralizing anti-TGF-β antibodies elicit heterogeneous therapeutic responses in a panel of murine metastatic breast cancer models (2015) (0)
- Abstract 2244: Functional interactions between estrogen-related-receptor β (ESRRB) and transforming growth factor-beta (TGF-β) in the regulation of breast cancer stem cell dynamics (2015) (0)
- Suppression of NF–Kappa B Signaling by SN50 Potentiates TNF–Alpha/JNK–Driven Cell Proliferation in Healing Corneal Epithelium and Has Therapeutic Effects on Corneal Alkali Burns in Mice (2005) (0)
- Role of smad 3 loss in resistance to the development of experimental colorectal fibrosis induced by trinitrobenzene suphonic acid. (2009) (0)
- Abstract 5484: Heterogeneity of response to anti-TGF-β antibody therapy in preclinical models. (2013) (0)
- Smads in the Fibrotic Response: Findings in the Smad3 Knockout Mouse (2008) (0)
- TGFβ Regulates BMP‐Smad Signaling in Mouse Pup Pulmonary Artery Smooth Muscle Cells via ALK1 (2017) (0)
- Transforming growth factor-beta expression in fibropapillomas induced by bovine papillomavirus type 1, in normal bovine skin, and in BPV-1-transformed cells. (1990) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kathleen Corey Flanders?
Kathleen Corey Flanders is affiliated with the following schools:
